Search

"A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients"

Originally aired on Tuesday, July 23rd, 2019 • Hosted by the Infectious Disease Community of Practice (IDCOP)

"A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients"
(Am J Transplant. 2019 Feb 15. doi: 10.1111/ajt.15315.)

In this article:
Through a large, multicenter trial of kidney transplant recipients, the authors of the article show that an assessment of CMV‐specific immunity using a novel ELISPOT assay is able to predict protection from CMV infection.

Speaker:
Camille Kotton, MD, FAST, FIDSA • Massachusetts General Hospital, Boston, MA

Moderator:
Raymund Razonable, MD • Mayo Clinic College of Medicine & Science, Rochester, MN

Watch Video

AST/AJT Journal Club

See all Journal Clubs

Donate

Donate

Donate

to the American Society of Transplantation

Career Center

Career Center

Career Center

Connecting Transplantation Talent with Opportunities

Patient Education

Patient Education

Educating the Community

The AST initiative, Power2Save, has great resources for patients and patient families.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.